Search

Your search keyword '"Siddiqui, Ali"' showing total 7 results
Start Over Author "Siddiqui, Ali" Journal endoscopy
7 results on '"Siddiqui, Ali"'

2. Endoscopic ultrasound-guided entero-enterostomy for the treatment of afferent loop syndrome: a multicenter experience

Author

Brewer Gutierrez, Olaya, additional, Irani, Shayan, additional, Ngamruengphong, Saowanee, additional, Aridi, Hanaa, additional, Kunda, Rastislav, additional, Siddiqui, Ali, additional, Dollhopf, Markus, additional, Nieto, Jose, additional, Chen, Yen-I, additional, Sahar, Nadav, additional, Bukhari, Majidah, additional, Sanaei, Omid, additional, Canto, Marcia, additional, Singh, Vikesh, additional, Kozarek, Richard, additional, and Khashab, Mouen, additional

Published
2018
Full Text
View/download PDF

3. Lumen-apposing covered self-expandable metal stents for short benign gastrointestinal strictures: a multicenter study

Author

Yang, Dennis, additional, Nieto, Jose, additional, Siddiqui, Ali, additional, Riff, Brian, additional, DiMaio, Christopher, additional, Nagula, Satish, additional, Ismail, Amr, additional, Ngamreungphong, Saowanee, additional, Khashab, Mouen, additional, Wagh, Mihir, additional, Tzimas, Demetrios, additional, Buscaglia, Jonathan, additional, Strand, Daniel, additional, Wang, Andrew, additional, Chauhan, Shailendra, additional, Forsmark, Christopher, additional, and Draganov, Peter, additional

Published
2017
Full Text
View/download PDF

4. Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study

Author

Ngamruengphong, Saowanee, additional, Sharaiha, Reem, additional, Sethi, Amrita, additional, Siddiqui, Ali, additional, DiMaio, Christopher, additional, Gonzalez, Susana, additional, Im, Jennifer, additional, Rogart, Jason, additional, Jagroop, Sophia, additional, Widmer, Jessica, additional, Hasan, Raza, additional, Laique, Sobia, additional, Gonda, Tamas, additional, Poneros, John, additional, Desai, Amit, additional, Tyberg, Amy, additional, Kumbhari, Vivek, additional, El Zein, Mohamad, additional, Abdelgelil, Ahmed, additional, Besharati, Sepideh, additional, Hernaez, Ruben, additional, Okolo, Patrick, additional, Singh, Vikesh, additional, Kalloo, Anthony, additional, Kahaleh, Michel, additional, and Khashab, Mouen, additional

Published
2016
Full Text
View/download PDF

6. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts

Author

Al-Haddad, Mohammad, additional, Kowalski, Thomas, additional, Siddiqui, Ali, additional, Mertz, Howard, additional, Mallat, Damien, additional, Haddad, Nadim, additional, Malhotra, Nidhi, additional, Sadowski, Brett, additional, Lybik, Mark, additional, Patel, Sandeep, additional, Okoh, Emuejevoke, additional, Rosenkranz, Laura, additional, Karasik, Michael, additional, Golioto, Michael, additional, Linder, Jeffrey, additional, and Catalano, Marc, additional

Published
2014
Full Text
View/download PDF

7. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts.

Author

Al-Haddad, Mohammad A., Kowalski, Thomas, Siddiqui, Ali, Mertz, Howard R., Mallat, Damien, Haddad, Nadim, Malhotra, Nidhi, Sadowski, Brett, Lybik, Mark J., Patel, Sandeep N., Okoh, Emuejevoke, Rosenkranz, Laura, Karasik, Michael, Golioto, Michael, Linder, Jeffrey, and Catalano, Marc F.

Subjects
PANCREATIC cysts, MOLECULAR pathology, PATHOLOGICAL physiology, PANCREATIC diseases, ADENOCARCINOMA
Abstract

Background and study aims: Current diagnostic testing is inadequate to determine the malignant potential of pancreatic cysts, resulting in overcautious patient management. Integrated molecular pathology (IMP) testing combines molecular analysis with first-line test results (cytology, imaging, and fluid chemistry) to assess the malignant potential of pancreatic cysts. This multicenter study aimed to determine the diagnostic accuracy of IMP for pancreatic adenocarcinoma, and the utility of IMP testing under current guideline recommendations for managing pancreatic cysts. Patients and methods: Patients who had undergone previous IMP testing as prescribed by their physician and for whom clinical outcomes were available from retrospective record review were included (n=492). Performance was determined by correlation between clinical outcome and previous IMP diagnosis ("benign"/"statistically indolent" vs. "statistically higher risk [SHR]"/ "aggressive") or an International Consensus Guideline (Sendai 2012) criteria model for "surveillance" vs. "surgery." The Cox proportional hazards model determined hazard ratios for malignancy. Results: Benign and statistically indolent IMP diagnoses had a 97% probability of benign followup for up to 7 years and 8 months from initial IMP testing. SHR and aggressive diagnoses had relative hazard ratios for malignancy of 30.8 and 76.3, respectively (both P<0.0001). Sendai surveillance criteria had a 97% probability of benign follow-up for up to 7 years and 8 months, but for surgical criteria the hazard ratio was only 9.0 (P<0.0001). In patients who met Sendai surgical criteria, benign and statistically indolent IMP diagnoses had a >93% probability of benign followup, with relative hazard ratios for SHR and aggressive IMP diagnoses of 16.1 and 50.2, respectively (both P<0.0001). Conclusion: IMP more accurately determined the malignant potential of pancreatic cysts than a Sendai 2012 guideline management criteria model. IMP may improve patient management by justifying more relaxed observation in patients meeting Sendai surveillance criteria. IMP can more accurately differentiate between the need for surveillance or surgery in patients meeting Sendai surgical criteria. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results